UV Safety Awareness Month 2026: The Latest Research, Trends, and Clinical Insights

As UV Safety Awareness Month shines a spotlight on sun protection each July, Dermatology Times delivered comprehensive coverage of the latest evidence, emerging therapies, and patient education challenges surrounding ultraviolet exposure and skin cancer prevention. From the approval of the first new sunscreen ingredient in decades to new research on the cumulative effects of photodamage, evolving skin cancer risks, and common misconceptions circulating on social media, this month's coverage explored the many ways dermatologists can help patients make informed decisions about sun safety. For even more insights, make sure to read our digital July issue!

UV Safety Awareness Month: The Lifelong Impact of Cumulative Photodamage

As ultraviolet (UV) exposure reaches its annual peak, Kathleen Suozzi, MD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut, emphasized that July’s UV Safety Awareness Month serves as an important reminder that sun protection remains the most effective strategy for preventing both skin cancer and premature skin aging. Although public awareness surrounding sunscreen and sun safety has improved—particularly among younger generations—Suozzi noted that many patients still underutilize proven protective measures. By the time many individuals seek dermatologic care for concerns related to prior sun exposure, significant cumulative damage has already occurred. She stressed that educating children and young adults about lifelong UV protection is essential, as much of the damage that contributes to skin cancer risk later in life begins during childhood.

Watch the full video here

FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years

The FDA has approved bemotrizinol as a permitted active ingredient in over-the-counter (OTC) sunscreen products, according to an agency announcement on June 9, 2026. The action marks the first addition to the OTC sunscreen monograph since the late 1990s and makes bemotrizinol the first new sunscreen active ingredient added through the streamlined administrative order process established by the CARES Act. The ingredient is approved for use in adults and children 6 months or older.

Read more

Social Media Mythbusters: The Summer Skin Care "Shutdown"

Every spring, a wave of online content resurfaces: creators advising followers to pause retinoids, exfoliating acids, and sometimes an entire active-ingredient routine for the summer months, on the theory that these products "can't be used in the sun" or will cause severe burns, dark spots, or irreversible damage if UV exposure isn't eliminated. The advice is usually presented as a blanket seasonal rule—stop in May, resume in September—rather than a nuanced discussion of any single ingredient's actual photobiology. The trend has real staying power because it contains a kernel of accurate pharmacology: several of the ingredients in question genuinely do interact with light and UV exposure in measurable ways. The problem is that "interacts with light" has been flattened into "must be discontinued," when the underlying data almost universally point toward a modification of use (better sun protection, evening application, dose titration) rather than cessation.

Read more

Summer Skin Protection Strategies for Patients With Atopic Dermatitis

Sun protection recommendations for patients with atopic dermatitis extend beyond UV protection alone, according to Christopher Bunick, MD, PhD. In a recent Dermatology Times interview, Bunick discussed how sunscreen ingredients, water exposure, and skin barrier support can influence disease activity while highlighting how effective systemic treatment can help restore patients' ability to enjoy summer activities. Because atopic dermatitis compromises the skin barrier, certain sunscreen ingredients may cause burning or stinging, potentially exacerbating disease symptoms. Bunick also noted that heat and sweating may trigger disease flares.

Watch the full video here

Sunscreen’s New Blind Spot: Fashion Trends, Tanning Myths, and the Rise of Gluteal Melanomas

Kelly English was in her mid-40s, working as an outdoor adventure guide, when a new exercise routine inadvertently may have saved her life. Having just started CrossFit in the summer of 2024, she noticed an irritated mole on her lower back and, while examining it, spotted something else: a lesion positioned in a part of the body most people never inspect.

“Just from looking at it, my dermatologist immediately said this was for sure melanoma,” English said in a conversation with Dermatology Times. A biopsy confirmed stage I superficial spreading melanoma. The location: the center of her buttocks.

Read more from our July cover story

TNF Inhibitors Linked to Increased Skin Cancer Risk in Long-Term Cohort Study

Long-term tumor necrosis factor alpha inhibitor (TNF-I) therapy was associated with significantly increased risks of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma in patients with chronic inflammatory disease, according to a large retrospective cohort study published in the Journal of the American Academy of Dermatology (JAAD). Investigators at Northwestern University analyzed 56,209 patients treated across dermatology, gastroenterology, and rheumatology clinics between July 1996 and January 2020, comparing 13,377 TNF-I-exposed patients with 42,832 unexposed patients. Adjusted hazard ratios ranged from 1.54 for melanoma to 1.99 for BCC.

Read more

How New UV Filters and Immunotherapy Are Changing Skin Health

As public awareness of sun protection continues to evolve, misconceptions surrounding sunscreen remain one of the greatest challenges facing dermatologists, according to Kathleen Suozzi, MD, associate professor of dermatology at Yale School of Medicine. Speaking during UV Safety Awareness Month, Suozzi highlighted the importance of evidence-based patient counseling while discussing recent advances that could reshape photoprotection and skin cancer prevention. Among the most common misconceptions she encounters is the false claim that sunscreen itself causes skin cancer. More recently, patients have expressed concerns about reports of systemic absorption of chemical sunscreen ingredients. Suozzi emphasized that although trace amounts of certain sunscreen filters have been detected in the bloodstream, decades of clinical use have not demonstrated evidence of harm from these low exposure levels. She reassures patients that the available data continue to support sunscreen as a safe and effective tool for preventing UV-induced skin damage.

Watch the full video here